title: Blood pressure variability in established L-NAME hypertension in rats.
abstract: METHODS
  Blood pressure variability was evaluated in conscious Wistar control rats and rats with established L-NAME hypertension (20 mg/kg per 24 h, 4 weeks).
  
  
  RESULTS
  Final systolic arterial pressure was 185+/-5 and 132+/-4 mm Hg in the Nomega-nitro-L-arginine methyl ester (L-NAME)-treated and control rats, respectively. The standard deviation of systolic arterial pressure in the L-NAME group was 70% greater than in the control rats, indicating a significant increase in the overall variability. Arterial pressure in the L-NAME rats exhibited aperiodical, abrupt rises and falls and data was grossly non-stationary. Blood pressure variability was therefore evaluated using Poincaré plot analysis. The variance of the difference (delta) between two successive values of systolic arterial pressure, determined for time intervals of 0.2 to 5 s (0.2 s increment), was always significantly higher in the L-NAME group compared with untreated animals. The variance of delta systolic arterial pressure increased with the time interval and plateaued for time intervals of 2.4 and 1.4 s in hypertensive and normotensive rats, respectively. These differences vanished when the sudden events oberved in L-NAME rats were omitted in the construction of Poincaré plots. Acute administration of prazosin (1 mg/kg), but not losartan (10 mg/kg) markedly reduced the variance of delta systolic arterial pressure in hypertensive rats.
  
  
  CONCLUSIONS
  Nitric oxide participates in the control of arterial pressure variability. The sympathetic nervous system seems to be a major determinant of the increased short-term variability of arterial pressure in this model.
authors.affiliation: Laboratoire de Pharmacologie, CNRS, UMR8604, Faculté de Médecine, Necker, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Blanc
authors.forename: P
authors.initials: P
authors.lastname: Ponchon
authors.forename: D
authors.initials: D
authors.lastname: Laude
authors.forename: J L
authors.initials: JL
authors.lastname: Elghozi
authors.forename: B
authors.initials: B
authors.lastname: Jover
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004791:Enzyme Inhibitors; D006973:Hypertension / Q000139:chemically induced* / Q000503:physiopathology*; D019808:Losartan / Q000494:pharmacology; D008297:Male; D019331:NG-Nitroarginine Methyl Ester; D011224:Prazosin / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
chemical_list: D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D019808:Losartan; D019331:NG-Nitroarginine Methyl Ester; D011224:Prazosin